Sympathy Moves On Biogen’s Big News
Big news for one stock can result in sympathy moves for other stocks. So, in the wake of big news for Biogen with the FDA… Read More »Sympathy Moves On Biogen’s Big News
Big news for one stock can result in sympathy moves for other stocks. So, in the wake of big news for Biogen with the FDA… Read More »Sympathy Moves On Biogen’s Big News
Known for their high yields, there are a lot of cons to closed-end funds (CEFs). But while the universe of CEFs may be described as… Read More »Separating Trash From Treasure In The CEF “Junkyard”
While stocks that make big moves – up or down – get all the attention, stocks that have done nothing in a while can sometimes… Read More »4 “Do Nothing” Stocks That May Be Worth Doing Something About
Of these 50 stocks that billionaire investors currently love, 32 pay dividends. Which of those make up the “top ten net big-gain billionaire-held dividend dogs”?… Read More »“Big-Gain Billionaire-Held Dividend Dogs”
If you only buy one stock, which stock should it be? Based on the hottest themes driving the market now, here are 11 “bullseye” investments… Read More »Set Yourself Up For A Bullseye With These 11 Investments
With demand strong, mortgage rates low, and their stocks trading at low valuations to expected earnings, homebuilders find themselves in a sweet spot. Which homebuilders… Read More »Home Sweet Home
While most dividend payers are pricey, there are still pockets of the income universe where value can be found. Here are five contrarian dividend strategies… Read More »Dividend Investing, On The Contrary
What exactly are mRNA and CRISPR technologies, what diseases can they be used to fight – and what are the best stocks and ETFs for… Read More »Gaining Exposure To mRNA And CRISPR
These three healthcare stocks are eliciting bullish sentiments from analysts, who see significant upside for each from current levels. CLICK HERE.
While the pandemic triggered a massive sell-off in all types of high-yield securities, this high-yielder used the crash to add a business line with the… Read More »A Post-“Coronacrash” High-Yield Turnaround Play